ArticleJournal of physiology and biochemistry2025
Elevated hydrostatic pressure dysregulates lipid metabolism of hepatocytes.
Article in Journal of physiology and biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Elevation of interstitial fluid hydrostatic pressure is observed in the early stages of fatty liver disease. We herein examined the hypothesis that elevated hydrostatic pressure dysregulates lipid metabolism in hepatocytes and thereby contributes to the progression of fatty liver disease. Human hepatocytes were exposed to 20 and 50 mmHg hydrostatic pressure for 1 and 24 h. RT-qPCR data on the expression of fatty acid metabolism-associated genes suggested the alteration of lipid metabolism. Although we did not observe an obvious change of cell growth, the accumulation of lipid droplets increased in hepatocytes at 1 and 24 h after the exposure to 20 and 50 mmHg hydrostatic pressure. Hydrostatic pressure exposure also enhanced the expression of p-ACC1, FASN, CPT1, and induced the translocation of CD36 to cell membrane. However, all changes under hydrostatic pressure exposure were effectively attenuated by the F-actin polymerization inhibitor latrunculin B. Our in vitro experimental data suggests that elevated interstitial fluid hydrostatic pressure under pathological conditions may dysregulate lipid metabolism to promote the development of liver fatty diseases through regulating the F-actin polymerization.
Indexed as
Identifiers
40785004What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.